W W B Wang

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. pmc A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
    Zhiwei Jiang
    Department of Health Statistics, School of Preventive Medicine, Fourth Military Medical University, NO, 169 Changle West Road, Xi an, Shaanxi, China
    Trials 15:500. 2014
  2. ncbi request reprint Statistical considerations for noninferiority/equivalence trials in vaccine development
    W W B Wang
    Clinical Biostatistics, Merck Research Laboratories, North Wales, Pennsylvania 19454, USA
    J Biopharm Stat 16:429-41. 2006

Collaborators

Detail Information

Publications2

  1. pmc A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
    Zhiwei Jiang
    Department of Health Statistics, School of Preventive Medicine, Fourth Military Medical University, NO, 169 Changle West Road, Xi an, Shaanxi, China
    Trials 15:500. 2014
    ..The building and evaluation of an association model between biomarkers and clinical outcomes are two equally important concerns regarding the prediction of clinical outcome. This paper is to address both issues in a Bayesian framework...
  2. ncbi request reprint Statistical considerations for noninferiority/equivalence trials in vaccine development
    W W B Wang
    Clinical Biostatistics, Merck Research Laboratories, North Wales, Pennsylvania 19454, USA
    J Biopharm Stat 16:429-41. 2006
    ....